NEW ORLEANS, Feb. 3, 2012 (GLOBE NEWSWIRE) -- A new drug that showed promise in animal studies and an early clinical trial didn’t improve disability among stroke patients, according to late-breaking research presented at the American Stroke Association’s International Stroke Conference 2012.
